
New Treatments and a Turning Point in Fatty Liver Disease Care with Dr. Meena Bansal
18.4.2026
0:00
9:40
In this episode, Meena Bansal, MD, FAASLD - System Chief, Division of Liver Diseases Director, MASH/NASH Center of Excellence, Icahn School of Medicine at Mount Sinai, discusses newly approved therapies for MASH and the growing impact of GLP-1 medications. She also shares insights on personalized treatment, early intervention, and the future of liver disease care.
Weitere Episoden von „Becker’s Healthcare Podcast“



Verpasse keine Episode von “Becker’s Healthcare Podcast” und abonniere ihn in der kostenlosen GetPodcast App.








